(19)
(11) EP 4 763 986 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
07.10.2026 Bulletin 2026/41

(43) Date of publication A2:
24.06.2026 Bulletin 2026/26

(21) Application number: 26162687.3

(22) Date of filing: 26.04.2022
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/86; C12N 2750/14143; C12N 2800/22; C12N 2830/00; C12N 2840/20; A61K 48/005; A61K 48/0066; A61K 48/0058; A61K 48/0075; C07K 2319/30; C07K 2319/32; C07K 2319/55; C07K 16/22; C07K 2317/56; C07K 2317/92; C12N 2320/31; C12N 2310/141; C12N 15/1136; C12N 15/1138; C12N 15/113
 
C-Sets:
C12N 2310/14, C12N 2310/531;
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 27.04.2021 US 202163180247 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
22796576.1 / 4330411

(71) Applicant: 4D Molecular Therapeutics Inc.
Emeryville, CA 94608 (US)

(72) Inventors:
  • BURNS, Christian
    Emeryville, California, 94608 (US)
  • CALTON, Melissa
    Emeryville, California, 94608 (US)
  • LEONG, Meredith
    Emeryville, California, 94608 (US)
  • SZYMANSKI, Paul
    Emeryville, California, 94608 (US)

(74) Representative: Mathys & Squire 
32 London Bridge Street The Shard
London SE1 9SG
London SE1 9SG (GB)

   


(54) COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR DISEASE ASSOCIATED WITH ANGIOGENESIS


(57) The present disclosure provides compositions and methods for the treatment of ocular diseases associated with angiogenesis, particularly wet age-related macular degeneration.







Search report















Search report